The Strategic Planning Committee report: the first step in a journey to recognize pediatric hospital medicine as a distinct discipline.

FINANCIAL DISCLOSURE: Dr Rauch has served as a consultant for Baxter Pharmaceuticals. Ongoing support for Dr Simon includes award K23NS062900 from the National Institute of Neurologic Disorders and Stroke, Seattle Children’s Center for Clinical and Translational Research and CTSA grant ULI RR025014 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the Child Health Corporation of America via the Pediatric Research in Inpatient Setting Network Executive Council. The other authors have indicated they have no fi nancial relationships relevant to this article to disclose. None of the sponsors participated in design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Its contents are solely the responsibility of the authors and do not necessarily represent the offi cial view of the NCRR or NIH. Christopher G. Maloney, MD, PhD,1 Suzanne Swanson Mendez, MD,2 Ricardo A. Quinonez, MD,3 Ryan S. Bode, MD,4 Chad K. Brands, MD,5 Steven Eagle, MD,6 Snezana Nena Osorio, MD, MS,7 Daniel Rauch, MD,8 and Tamara D. Simon, MD, MSPH9,10